| 发明名称 |
Composition comprising degarelix for use in the treatment of prostate cancer in a subject identified as being at risk for cardiovascular disease |
| 摘要 |
The invention provides uses and dosing regimens of a gonadotrophin releasing hormone (GnRH) antagonist for the treatment of prostate cancer in a subject who is at risk for cardiovascular disease. |
| 申请公布号 |
IL207295(A) |
申请公布日期 |
2015.03.31 |
| 申请号 |
IL20100207295 |
申请日期 |
2010.07.29 |
| 申请人 |
FERRING INTERNATIONAL CENTER SA |
发明人 |
|
| 分类号 |
|
主分类号 |
|
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
